Literature DB >> 17000294

Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation?

Tara Karamlou1, Eugene H Blackstone, John A Hawkins, Marshall L Jacobs, Kirk R Kanter, John W Brown, Constantine Mavroudis, Christopher A Caldarone, William G Williams, Brian W McCrindle.   

Abstract

OBJECTIVES: We sought to examine risk factors for pulmonary conduit failure or dysfunction in infants less than age 2 years at initial implantation.
METHODS: From 2002 to 2005, 241 children at 17 institutions were discharged alive after initial pulmonary conduit insertion. Initial conduit type was pulmonary allograft in 37%, aortic allograft in 29%, bovine jugular venous valved conduit in 25%, porcine heterograft in 2%, and decellularized allograft in 7%. Parametric hazard analysis determined time-related prevalence and associated risk factors for pulmonary conduit intervention and explantation. Serial echocardiographic measurements after conduit implant were analyzed by mixed regression models.
RESULTS: There were 89 first conduit-related interventions after discharge and 37 initial conduit explants were performed. First conduit intervention occurred at a constant rate, with a prevalence of 58% at 3 years from initial implant. Pulmonary conduit explantation (30% at 3 years) was characterized by an early-rising risk, suggesting that catheter-based intervention effectively blunts this early initial risk. Common risk-factors for first conduit intervention and explantation were smaller conduit Z-score and younger age at initial conduit implant, and the presence of pulmonary arborization abnormalities or stenoses. Pulmonary conduit peak gradient and regurgitation progressed nonlinearly in all patients over time. Gradient progressed more rapidly in children with aortic allografts and when initial conduit Z-score was less than +1 or more than +3. Pulmonary conduit regurgitation also progressed more rapidly in children with initial conduit Z-score greater than +3 and in those without jugular venous valved conduits, especially aortic allografts.
CONCLUSIONS: Pulmonary conduit durability and hemodynamic function in patients undergoing initial conduit insertion at less than age 2 years can be improved by using pulmonary conduits with Z-scores between +1 and +3.

Entities:  

Mesh:

Year:  2006        PMID: 17000294     DOI: 10.1016/j.jtcvs.2006.06.034

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Bidirectional Glenn shunt as an adjunct to surgical repair of congenital heart disease associated with pulmonary outflow obstruction: relevance of the fluid pressure drop-flow relationship.

Authors:  Robert Ascuitto; Nancy Ross-Ascuitto; Joshua Wiesman; Serafin Deleon
Journal:  Pediatr Cardiol       Date:  2008-06-13       Impact factor: 1.655

2.  A geometrically adaptable heart valve replacement.

Authors:  Sophie C Hofferberth; Mossab Y Saeed; Lara Tomholt; Matheus C Fernandes; Christopher J Payne; Karl Price; Gerald R Marx; Jesse J Esch; David W Brown; Jonathan Brown; Peter E Hammer; Richard W Bianco; James C Weaver; Elazer R Edelman; Pedro J Del Nido
Journal:  Sci Transl Med       Date:  2020-02-19       Impact factor: 17.956

Review 3.  Current status of right ventricular outflow tract reconstruction: complete translation of a review article originally published in Kyobu Geka 2014;67:65-77.

Authors:  Yusuke Yamamoto; Masaaki Yamagishi; Takako Miyazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-12-13

4.  Percutaneous balloon dilation of Carpentier-Edwards porcine-valved right ventricle-to-pulmonary artery conduits.

Authors:  Amanda C Hall; Daniel E Miga; Glenn T Leonard; Hongyue Wang; Rae-Ellen Kavey; George M Alfieris
Journal:  Pediatr Cardiol       Date:  2012-12-11       Impact factor: 1.655

5.  Linking the congenital heart surgery databases of the Society of Thoracic Surgeons and the Congenital Heart Surgeons' Society: part 1--rationale and methodology.

Authors:  Jeffrey P Jacobs; Sara K Pasquali; Erle Austin; J William Gaynor; Carl Backer; Jennifer C Hirsch-Romano; William G Williams; Christopher A Caldarone; Brian W McCrindle; Karen E Graham; Rachel S Dokholyan; Gregory J Shook; Jennifer Poteat; Maulik V Baxi; Tara Karamlou; Eugene H Blackstone; Constantine Mavroudis; John E Mayer; Richard A Jonas; Marshall L Jacobs
Journal:  World J Pediatr Congenit Heart Surg       Date:  2014-04

6.  In vivo implantation of 3-dimensional printed customized branched tissue engineered vascular graft in a porcine model.

Authors:  Enoch Yeung; Takahiro Inoue; Hiroshi Matsushita; Justin Opfermann; Paige Mass; Seda Aslan; Jed Johnson; Kevin Nelson; Byeol Kim; Laura Olivieri; Axel Krieger; Narutoshi Hibino
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-09       Impact factor: 5.209

7.  Wharton's Jelly-Mesenchymal Stem Cell-Engineered Conduit for Pulmonary Artery Reconstruction in Growing Piglets.

Authors:  Filippo Rapetto; Dominga Iacobazzi; Srinivas A Narayan; Katie Skeffington; Tasneem Salih; Shahd Mostafa; Valeria V Alvino; Adrian Upex; Paolo Madeddu; Mohamed T Ghorbel; Massimo Caputo
Journal:  JACC Basic Transl Sci       Date:  2022-02-23

Review 8.  Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Authors:  Chenggang Li; Bo Xie; Ruizhe Tan; Lijin Liang; Zhaoxiang Peng; Qi Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04

9.  Hand-Made Polytetrafluoroethylene Tricuspid-Valved Conduit for Surgical Reconstruction of the Right Ventricular Outflow Tract in a Child With Truncus Arteriosus.

Authors:  Vishal V Bhende; Tanishq S Sharma; Hardil P Majmudar; Krishnan Ganapathy Subramaniam; Deepakkumar V Mehta; Amit Kumar; Purvi R Patel; Gurpreet Panesar; Kunal Soni; Kartik B Dhami; Nirja Patel; Sohilkhan R Pathan
Journal:  Cureus       Date:  2022-07-20

10.  Commentary: In search of the ideal right ventricle-to-pulmonary artery conduit: Is perfect the enemy of good, or will it foster excellence?

Authors:  Minoo N Kavarana
Journal:  JTCVS Open       Date:  2020-09-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.